Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Monday, August 17, 2026

Snapshot: Aug 17, 2026 · 6:00 PM 100 stocks analyzed

Flat Day

Mon, Aug 17, 2026 Divergent High

Small caps surged while large caps stumbled in a divergent tape where high-dispersion single-stock swings overwhelmed muted index moves, with healthcare leading a rally of 50 ga…

55% Extreme single-stock dispersion dominated the day as 50 gainers averaged +28.4% and 50 losers averaged -24.3%, with named catalysts like XOS's Air Force contract (+82%), IVF's profitability report (+72%), and EYPT's failed Phase 3 trial (-67%) creating a stock-pickers' market that eclipsed the nearly flat broad indices.
30% Russell 2000 outpaced the S&P 500 by +1.4 percentage points, rallying +1.33% while large-cap indices fell, signaling a small-cap rotation that lifted mid-caps +1.18% and reflected investor appetite for beaten-down industrials and healthcare names following sector concentration shifts.
15% Healthcare stocks claimed 35% of gainers while representing only 26% of losers, a structural bullish tilt underscored by the debut of five new names including Vogenx's +28.6% IPO and a three-day winning streak in both CDTG and MDXH, suggesting selective rotation into neglected micro-caps and biotech turnarounds.

Healthcare drove 35% of gainers 5 names returned after long absences CDTG · 3-day gainers streak MDXH · 3-day gainers streak VOGX — first appearance UFI — first appearance

Market Regime

Mon, Aug 17, 2026 Risk-On conf: medium macro · prototype

+44

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.2 p9 Drawdown-0.7% Held11d · established SinceAug 3

Top drivers: VIX percentile ▲ S&P 20d return ▲ S&P vs 50d avg ▲

processId: history-market-regime

Market Indexes

Mon, Aug 17, 2026 13

S&P 500

7,745.06

−8.05

-0.10%

Dow Jones

53,459.78

−516.20

-0.96%

NASDAQ Composite

26,644.91

+39.55

+0.15%

NASDAQ 100

29,995.38

+373.58

+1.26%

DJ US Total Market

76,829.27

+48.09

+0.06%

Russell 1000

4,223.67

−2.11

-0.05%

S&P MidCap 400

3,917.11

+45.56

+1.18%

Russell 2000

3,057.54

+40.14

+1.33%

Russell 2500

1,304.35

−5.63

-0.43%

Russell 3000

4,411.21

+0.34

+0.01%

Nasdaq Financial-100

7,628.20

−30.77

-0.40%

NIFTY 50

24,287.65

−184.05

-0.75%

VIX

15.19

−0.09

-0.59%

Biggest Gainers

Mon, Aug 17, 2026 50

DSX.WT

Diana Shipping Inc. WT

$0.44+$0.22

+100.0%

XOS

Xos, Inc.Industrials

$2.10+$1.72

+81.9%

NASDAQ · Mkt cap $41 M

Xos surged 81.9% after securing a U.S. Air Force contract to deliver a prototype mobile charging system, marking the company's entry into the defense market through a competitive selection process.

The headline confirms a specific catalyst: Xos was selected by the U.S. Air Force Global Strike Command Rapid Capabilities Division to deliver a ruggedized energy storage prototype for electrified support equipment and vehicles. This represents both strategic validation and revenue diversification into the defense sector, a higher-margin market segment typically valued favorably by investors. For an electric vehicle and energy storage company, a defense contract win signals potential for scale beyond commercial trucking and establishes credibility with a major, creditworthy customer. The timing of the news release on 2026-08-17 aligns with the trading day spike, establishing a direct causal relationship between announcement and price movement.

IVF

NAYA Biosciences, Inc.Healthcare

$1.53+$0.73

+72.3%

NASDAQ · Mkt cap $2.0 M

INVO Fertility (IVF) surged 72% after reporting Q2 2026 results showing 17% revenue growth to $2.18 million and achieving clinic-level profitability on an adjusted EBITDA basis, driven by the Family Beginnings acquisition and organic growth.

The earnings announcement provided clear positive catalysts: a 17% year-over-year revenue increase, the first full-quarter contribution from the Family Beginnings acquisition, and the achievement of profitability at the clinic platform level on an adjusted EBITDA basis. For a micro-cap fertility services company trading at $1.53, profitability at the clinic level combined with double-digit revenue growth represents a meaningful inflection point. The disciplined acquisition strategy mentioned in the headlines suggests management is executing a coherent growth playbook. The stock's rank as the third biggest gainer of the day implies this was a market-wide positive surprise relative to expectations, typical for micro-cap stocks where earnings beats can drive outsized moves.

OSRH

Bellevue Life Sciences Acquisition Corp.Healthcare

$0.60+$0.22

+72.1%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, so the 72% gain likely reflects a technical rebound, delayed reaction to an earlier announcement, or typical small-cap volatility in a SPAC trading at a very low price.

Bellevue Life Sciences Acquisition Corp. is a blank-check company trading at $0.60, and the absence of news in the last 48 hours makes it difficult to pinpoint a specific catalyst. However, SPACs at this price level are prone to sharp moves driven by technical factors, including short covering, options-driven activity, or retail interest. The company may have announced a merger or business combination prior to the 48-hour window, and the market may be re-evaluating that deal. Alternatively, the move could reflect a delayed market reaction to a press release issued slightly beyond the news feed capture window, or a routine bounce following oversold conditions. Without recent headlines or context about pending deadlines or shareholder votes, attribution remains speculative.

CDTG

CDT Environmental Technology Investment Holdings Limited ordinary sharesIndustrials

$2.80+$1.25

+70.2%

NASDAQ · Mkt cap $9.9 M

No news headlines were found in the last 48 hours, so the 70% gain likely reflects a technical bounce, delayed announcement, or trader activity rather than a specific company-driven catalyst.

CDT Environmental Technology Investment Holdings Limited experienced a dramatic 70% single-day rally on August 17, 2026, but no news headlines from the prior 48 hours are available to explain the move. This absence of contemporaneous reporting is significant because a jump of this magnitude typically requires either a major corporate announcement or market-moving catalyst. The stock could have responded to a technical rebound from oversold conditions, short covering, general sector rotation into environmental technology plays, or an announcement made after market close on August 16 that is not yet reflected in the headline feed provided. Without access to intraday trading data, after-hours filings, or broker bulletins, the specific trigger remains unclear.

SGLY

Singularity Future Technology Ltd.Industrials

$4.61+$2.98

+67.1%

NASDAQ · Mkt cap $2.7 M

No news headlines were found in the last 48 hours, so the 67% gain cannot be attributed to a specific reported event. The move likely reflects technical factors, unconfirmed rumors, or delayed market reaction to older information.

The absence of recent headlines within the 48-hour window is notable for a stock that jumped to the sixth-largest gainer of the day. SGLY is a micro-cap technology company, and such stocks are prone to sharp moves driven by factors outside traditional news coverage: technical breakouts from low liquidity, social media sentiment, retail trading coordination, options-related activity, or delayed market digestion of press releases not yet picked up by major RSS feeds. Without access to the company's recent investor relations announcements, social media activity, or trading data, pinpointing the specific trigger is not possible. The move could also reflect a reversal from prior weakness or a short-squeeze dynamic common in illiquid small-cap stocks.

WFF

WF Holding Limited Ordinary SharesIndustrials

$2.01+$0.83

+58.9%

NASDAQ · Mkt cap $20 M

No news headlines were found in the last 48 hours, so the 58.87% spike cannot be attributed to a specific announced catalyst. The jump is likely driven by technical factors, retail activity, or unindexed market rumors.

The absence of any news in the Yahoo Finance RSS feed over the past two days means we cannot point to earnings, guidance, FDA actions, M&A, or other corporate events as the direct cause of this move. WF Holding Limited is a smaller-cap stock trading on NASDAQ, and such stocks are often susceptible to sharp intraday rallies driven by short covering, unusual options activity, social media momentum, or rebalancing. Without access to trading volume, short interest data, or real-time market commentary, it is impossible to determine which of these mechanisms (if any) triggered the move. A delayed announcement or investor discovery of older news is also theoretically possible but cannot be confirmed from the available evidence.

RETO

Reto Eco-solutions IncBasic Materials

$1.65+$0.46

+38.0%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 38% gain cannot be directly attributed to a disclosed catalyst; the move likely reflects technical trading, a delayed or unannounced development, or market sentiment specific to the eco-solutions sector.

The absence of any Yahoo Finance RSS headlines in the 48-hour window preceding this strong rally makes it impossible to pinpoint a specific news-driven catalyst. Reto Eco-Solutions operates in the environmental solutions space, which can be sensitive to regulatory shifts, ESG capital flows, or sector-wide momentum. Without disclosed information, the jump could reflect several generic categories: a technical breakout or short squeeze, a press release issued outside the Yahoo Finance feed, an unconfirmed rumor or social media attention, or delayed market reaction to an earlier announcement. Small-cap stocks like RETO, trading at $1.65, tend to experience outsized swings on thin volumes and limited analyst coverage, making them particularly prone to momentum-driven moves independent of fundamental news.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.08+$0.02

+32.0%

NASDAQ · Mkt cap $5.5 M

No news headlines were found in the last 48 hours to explain the 32% surge in HEPA stock, so the driver remains unclear; the move may reflect technical trading, delayed announcements, or sector-wide momentum in small-cap biotech.

The absence of any news headlines in the Yahoo Finance RSS feed in the last 48 hours means we cannot point to a specific catalyst such as an earnings release, FDA decision, clinical trial result, partnership announcement, or guidance update. For a micro-cap pharmaceutical stock like Hepion trading at $0.08, price swings of this magnitude are not uncommon and can be driven by several factors. Given HEPA's profile as a small-cap biotech, the jump could reflect a short squeeze on a thinly traded stock, renewed interest following a delayed press release or conference presentation not yet indexed in the headline feed, momentum trading among retail investors, or sector rotation into smaller-cap pharma plays. Without contemporaneous news, pinpointing the exact cause is not possible.

STFS

Star Fashion Culture Holdings LimitedCommunication Services

$4.23+$1.21

+30.9%

NASDAQ · Mkt cap $5.3 M

No news headlines were found in the last 48 hours, so the 31% gain cannot be attributed to a specific announced catalyst. The move is likely driven by technical factors, delayed reporting of news, or market rumors.

Star Fashion Culture Holdings Limited jumped 31% on August 17, 2026, but no corresponding news headlines appear in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect between price action and reported news creates uncertainty about the true catalyst. For a small-cap fashion retailer trading on NASDAQ, typical drivers of sharp single-day rallies include short covering if the stock is heavily shorted, technical breakouts above key resistance levels, sector-wide momentum in apparel retail, or rumors about M&A, licensing deals, or management changes that may not yet be formally announced or widely distributed through major news feeds. Without access to real-time trading data, social media sentiment, or private news services, we cannot determine which mechanism drove this particular move.

SLE

Super League Gaming IncCommunication Services

$3.00+$0.68

+29.8%

NASDAQ · Mkt cap $6.6 M

No news headlines were published in the last 48 hours on SLE, so the 29.83% gain cannot be directly attributed to any identified catalyst. The move likely reflects technical trading, market sentiment shift, or an untracked announcement.

Super League Gaming Inc (SLE) posted an 11th-place daily gain of nearly 30% on August 17, 2026, but no financial news, earnings releases, partnership announcements, or material events appear in the Yahoo Finance RSS feed for the preceding 48 hours. This absence of reported catalysts makes direct attribution impossible. For a micro-cap or lower-liquidity stock like SLE, sudden large moves absent news often stem from several categories: short-covering in a thinly traded name, retail social-media coordination, technical bounces off support levels, or delayed disclosure of material information not yet picked up by major news aggregators. Without access to intraday volume, short interest data, options activity, or insider trades, identifying which mechanism drove this move is speculative.

REED

Reed's IncConsumer Defensive

$1.19+$0.27

+29.3%

NYSE · Mkt cap $13 M

No news headlines were published in the last 48 hours for REED, so the 29% gain today cannot be traced to a specific disclosed event. The jump likely reflects technical trading, short covering, or undisclosed company news.

Reed's Inc experienced a substantial single-day rally with no corresponding news coverage in the provided sources. This disconnect suggests either a delayed market reaction to older news, technical factors such as short-squeeze activity given the stock's low price point and likely retail attention, or internal company developments not yet widely reported. Small-cap consumer staple stocks like REED can exhibit outsized daily moves on low volume and algorithmic activity. Without headline confirmation, we cannot rule out rumors, insider activity becoming visible through volume spikes, or sector-wide momentum. The stock's penny-stock-adjacent valuation makes it susceptible to retail-driven volatility independent of fundamentals.

CBRG

Chain Bridge IFinancial Services

$6.00+$1.35

+29.0%

VOGX

Vogenx IncHealthcare

$15.87+$4.22

+28.6%

NASDAQ · Mkt cap $322 M

Vogenx completed its initial public offering on August 17, 2026, raising $81.3 million with Jones Trading as sole book-running manager, which directly triggered the 28.55% intraday gain as the stock began trading publicly.

The news headline confirms that Vogenx, a clinical-stage biopharmaceutical company, went public on the date of this snapshot through an $81.3 million IPO underwritten by Jones Trading. IPO day price movements are typically driven by initial supply-demand dynamics as the stock enters public trading for the first time, opening momentum from retail and institutional buyers, and the market's initial valuation of the company relative to its IPO pricing. A 28.55% pop is significant but not unusual for smaller biotech IPOs, especially those that price at levels the market perceives as attractive. The fact that Vogenx is described as clinical-stage (pre-revenue or early-stage development) may also amplify volatility as investors price in the speculative value of its pipeline. No other news regarding clinical results, partnerships, or business developments is provided in the 48-hour window.

MDXH

MDxHealth SAHealthcare

$0.84+$0.19

+26.6%

NASDAQ · Mkt cap $39 M

No news headlines were found in the last 48 hours, so the 26.58% gain likely reflects technical trading, short covering, or an announcement not yet indexed by Yahoo Finance RSS.

MDxHealth is a molecular diagnostics company with a history of volatile trading, particularly in lower-priced stocks where percentage moves can be large on modest absolute volume. The absence of headlines in the Yahoo Finance feed does not rule out catalysts that may have been announced via company press release, social media, or specialized investor channels but not yet picked up by mainstream RSS aggregators. Possible drivers in this category include clinical trial results, partnership announcements, reimbursement decisions, or regulatory updates specific to the company's prostate cancer or other diagnostic tests. Alternatively, the move could reflect short squeeze dynamics or algorithmic/technical trading in a thinly traded security. Without access to company announcements or trading volume data, we cannot distinguish between these scenarios.

HWH

HWH International IncConsumer Cyclical

$1.94+$0.45

+26.4%

NASDAQ · Mkt cap $16 M

No news was reported in the last 48 hours, so the 26% jump likely reflects a technical rebound, short covering, or untracked corporate announcement; without headlines or context, the driver remains unclear.

Yahoo Finance returned no headlines for HWH International in the 48-hour window prior to this 26% gain, which is the largest limitation in explaining the move. A stock ranked 16th in daily gainers with such magnitude typically responds to a specific catalyst: earnings surprise, a contract win, FDA or regulatory approval, debt restructuring, insider buying, or short-squeeze activity. Given that HWH trades at $1.94 with a one-day swing of 26%, it appears to be a micro-cap or penny stock, a category prone to volatile moves on limited volume and retail interest. Without accompanying news, the most likely explanations fall into either technical mean reversion (if the stock had recently fallen sharply), short-covering demand, or a corporate announcement that has not yet appeared in the RSS feed lag or distribution delay.

SNYR

Synergy CHC Corp.Healthcare

$0.15+$0.03

+25.7%

NASDAQ · Mkt cap $1.6 M

No news headlines were found in the last 48 hours, so the 25.74% gain is not directly attributable to any reported event. The move likely reflects technical trading, retail interest, or delayed news not yet indexed.

The absence of recent headlines makes it impossible to point to a specific catalyst such as earnings, regulatory approval, partnership, or guidance change. SNYR is a micro-cap stock trading at $0.15, a category where price moves are often driven by factors other than fundamental news: technical breakouts from low floats, short covering, social media promotion among retail traders, or insider activity that precedes formal disclosure. Without access to insider trades, short interest data, or real-time order flow, we cannot determine which of these mechanisms is at work here. It is also possible that relevant news exists but has not yet been picked up by the Yahoo Finance RSS feed used for this analysis.

AGPU

Predictive Oncology Inc.Technology

$10.62+$2.12

+25.6%

NASDAQ · Mkt cap $23 M

Axe Compute (AGPU) secured a $500+ million, five-year hosting agreement with Duos Technologies for 55 MW of AI data center capacity, announced on 2026-08-17, driving a 25.6% gain as a major commercial validation of its neocloud AI infrastructure business.

The news headlines directly identify a major commercial contract win: Axe Compute announced dual press releases (alongside Duos Technologies) on 2026-08-17 morning detailing agreements for 55 MW of AI data center capacity valued at over $500 million across multiple U.S. locations. This represents a significant revenue milestone and validates demand for AGPU's AI infrastructure offerings. The timing of the announcement (morning of 2026-08-17) aligns precisely with the stock's intraday surge to 18 biggest gainer. A third headline characterizes the deal as worth "over 18X" Duos' 2025 revenue, reinforcing its scale. For an AI infrastructure company, securing long-term, large-scale capacity commitments is a material positive signal of market traction and revenue visibility, which explains the sharp upside move.

DMIIR

Drugs Made In America Acquisition II Corp. Right

$0.09+$0.02

+24.8%

NASDAQ

No headlines were found in the last 48 hours, but the 24.75% gain in DMIIR rights warrants consideration of typical SPAC dynamics, delayed news digestion, or technical factors common to illiquid microcap securities.

DMIIR is a SPAC rights unit, a class of security that trades with low liquidity and often experiences outsized percentage moves on modest dollar volume. The absence of breaking news in the past 48 hours suggests the catalyst was either announced more than 48 hours ago and is now being digested by the market, occurred internally without public disclosure yet, or is a technical/momentum-driven rally in a thinly traded instrument. SPAC-related securities can jump on merger progress updates, sponsor capital commitments, or regulatory approvals that may have been released just outside the news window. Alternatively, the move may reflect short covering or retail accumulation on a low-priced right. Without headline confirmation, the exact driver remains unclear, but SPAC rights typically respond to events directly tied to the underlying acquisition timeline or deal status.

AIOS

NiSun International Enterprise Development Group Co., Ltd. Class AFinancial Services

$14.26+$2.95

+24.5%

NASDAQ · Mkt cap $2.7 M

About AIOS Tech Inc.

Listed in this day's movers as “NiSun International Enterprise Development Group Co., Ltd. Class A” — the company profile carries a different name (rename, or the ticker changed hands). The read below follows the profile.

AIOS Tech Inc. functions as an investment holding company, providing technology-centric integrated financing solutions and comprehensive supply chain services throughout China. The company specializes in offering sophisticated financing services to small and medium-sized enterprises (SMEs). This includes the conceptualization and detailing of debt financial products, alongside providing strategic advisory to underwriters and various financial institutions. Furthermore, AIOS facilitates the entire financing process, from initial due diligence and regulatory registration to client acquisition, investor education, and crucial intermediary and advisory matching services. On the supply chain front, the company leverages cutting-edge technologies such as big data, artificial intelligence (AI), the Internet of Things (IoT), and blockchain. These innovations underpin its supply chain management solutions, primarily serving sectors like agriculture, infrastructure, maritime logistics, energy, and plastics products. Beyond management, AIOS engages in extensive supply chain trading across diverse industries, including agriculture, coal, new energy technology, construction, e-commerce, retail, and the food and vegetable sectors. Additionally, through its Huijingshe platform, the company provides direct banking services, specializing in asset allocation and financial planning for both institutional and individual investors. Rounding out its portfolio, AIOS offers a wide array of auxiliary services. These range from customer management, consulting, and advisory support to comprehensive product inspection, testing, documentation, and freight forwarding. The company also handles customs clearance, warehousing, strategic planning, sourcing, procurement, and all aspects of logistics and transportation, including storage. Formerly known as Nisun International Enterprise Development Group Co., Ltd., the company officially adopted the name AIOS Tech Inc. in February 2026. Established in 2005, its operations are headquartered in Shanghai, China.

Financial - Credit Services · ir.aiosinc.com

No news headlines were found in the last 48 hours, so the cause of AIOS's 24.48% gain cannot be attributed to a reported event. The jump likely reflects either a delayed announcement, technical factors, or market-specific catalysts not captured in standard news feeds.

The absence of recent headlines is notable given the magnitude of the move, which placed AIOS at the 20th biggest gainer on the day. For a relatively smaller-cap equity, a 24% single-day rally typically requires a catalyst such as earnings beats, contract awards, partnership announcements, FDA approvals, or insider activity. Without news confirmation, several generic possibilities remain: a delayed or early morning announcement not yet indexed by Yahoo Finance RSS, short covering or algorithmic trading activity, options-related hedging repositioning, or promotional activity in retail trading communities. The security's history (NiSun is a China-based software and IT consulting firm traded on NASDAQ) can be volatile, but without specific structural insights into current positioning or known squeeze dynamics, attribution remains speculative.

XHLD

TEN Holdings, Inc. Common StockCommunication Services

$7.39+$1.41

+24.3%

NASDAQ · Mkt cap $92 M

No news headlines were found in the last 48 hours, so the 24.27% gain likely reflects a delayed market reaction to an earlier announcement, technical or algorithmic trading, or undisclosed corporate news not yet syndicated to Yahoo Finance.

TEN Holdings experienced a substantial single-day jump of over 24%, ranking it among the top 21 gainers on NASDAQ, yet no recent news headlines appear in the Yahoo Finance RSS feed covering the last 48 hours. This disconnect suggests several possibilities. First, the catalyst may predate the 48-hour window and is only now moving the stock due to delayed market absorption or accumulation by algorithmic traders. Second, the news may exist but has not yet been picked up by major RSS aggregators, meaning it could be a press release, SEC filing, or announcement via investor relations channels that hasn't spread widely. Third, this could reflect short covering, technical rebound from oversold conditions, or broader sector momentum. Without substantive company-specific information or structural characteristics of XHLD visible in the available data, assigning a confident root cause is not possible. Holdings companies and smaller-cap stocks can experience volatile single-day swings on thin volume or rumor.

GRNQ

Greenpro Capital CorpIndustrials

$10.04+$1.94

+24.0%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours, so the 23.95% gain cannot be tied to a specific announced catalyst. The jump likely reflects technical trading, delayed news pickup, or market-wide sector movement.

Greenpro Capital Corp (GRNQ) jumped nearly 24% on 2026-08-17 with zero financial news identified in the Yahoo Finance RSS feed over the prior 48 hours. This absence of grounding makes the move harder to explain definitively. For a micro-cap or small-cap fintech stock like GRNQ, gainers of this magnitude without headline support typically reflect one of several patterns: short covering or momentum squeeze if the stock has significant short interest, technical breakout above a resistance level attracting algorithmic or retail flows, a delayed or off-market news event not yet widely indexed, or sector-wide strength in fintech or payments if competitors rallied. Without access to intraday trading data, insider trading records, or regulatory filings released that day, pinpointing the exact cause remains speculative. The absence of material news does not rule out a legitimate catalyst; it simply means the evidence available here does not identify it.

UFI

Unifi IncConsumer Cyclical

$7.95+$1.53

+23.8%

NYSE · Mkt cap $146 M

Unifi announced a $60 million asset sale to deleverage its balance sheet, a material step toward financial restructuring that likely drove the 23.83% gain.

On August 17, 2026, Unifi announced an agreement to sell non-strategic U.S. real estate with expected gross proceeds of $60 million earmarked for debt reduction and balance sheet transformation. This is a concrete capital allocation event that addresses leverage—a primary concern for investors in companies with debt burdens. The announcement came during market hours and was flagged as news on the same day as the price jump, establishing a clear temporal link. The sale signals management action on financial health without requiring operational improvements or external market conditions. For a yarn and recycled-fiber manufacturer like Unifi, which typically carries meaningful debt, a $60 million deleveraging move represents material progress and may have triggered short covering or reassessment of credit risk by the market.

ADIL

Adial Pharmaceuticals IncHealthcare

$4.99+$0.94

+23.1%

NASDAQ · Mkt cap $15 M

Adial Pharmaceuticals announced completion of its acquisition of Azora Therapeutics and closed a $32 million initial funding round, adding a late-stage ulcerative colitis candidate to its pipeline, driving the +23% gain.

The headline confirms a material corporate event: Adial completed an acquisition of Azora Therapeutics and simultaneously closed an initial tranche of $32 million in financing. The acquired asset, AT177, is a fully synthetic oral candidate targeting ulcerative colitis via aryl hydrocarbon receptor agonism, representing pipeline expansion into a clinical-stage therapeutic. The financing component demonstrates capital strength to fund development. For a small-cap biopharmaceutical stock, successful M&A coupled with secured funding typically signals de-risking of the business model and expanded commercial opportunity. The headline was released during market hours on 2026-08-17, aligning with the same-day price surge. No earnings miss, FDA rejection, or other negative event is apparent in the provided news.

INBS

Intelligent Bio Solutions Inc.Healthcare

$3.33+$0.57

+20.7%

NASDAQ · Mkt cap $8.1 M

INBS jumped 20.65% following announcement of ISO recertification aligned with FDA's newly amended Quality Management System Regulation, strengthening the company's regulatory pathway toward FDA clearance.

The single headline documents INBS's recertification under ISO standards that now align with the FDA's updated Quality Management System Regulation. The company frames this explicitly as support for its regulatory strategy pursuing FDA clearance. For a small-cap biotech or medical device company, FDA clearance represents a major value inflection point—recertification demonstrates operational readiness and regulatory compliance, reducing perceived risk of the approval path. The timing of the announcement (same day as the 20% move) and the direct linkage to FDA strategy suggest investors interpreted this credential as material de-risking of a key milestone. Without additional context on the company's pipeline status or prior regulatory stumbles, we cannot quantify how much this certification advances the timeline, but the market's response indicates it was viewed as a positive step.

BANL

CBL International Limited - Ordinary SharesEnergy

$10.48+$2.01

+20.6%

NASDAQ · Mkt cap $26 M

No news headlines were found in the last 48 hours, so the 20.62% gain cannot be attributed to a specific disclosed event. The move likely reflects either delayed market reaction to an older announcement, technical trading, or undisclosed company news.

Despite a substantial single-day gain that placed BANL in the top 26 gainers on NASDAQ, no recent news headlines are available to explain the price action. This creates a significant gap between the magnitude of the move and publicly reported catalysts. For a stock like CBL International Limited, which appears to be a real estate or business services company based on the ticker and name, large single-day moves without contemporaneous headlines could result from several sources: a delayed market reaction to earnings or guidance released just outside the 48-hour window, short covering or technical momentum trading, insider transactions becoming public, or an announcement made through channels not captured in this RSS feed. Without corroborating headline evidence, any explanation remains speculative rather than grounded in disclosed information.

USDEW

StablecoinX Inc. Warrants

$0.60+$0.10

+20.0%

MLEC

MOOLEC SCIENCE SAHealthcare

$8.57+$1.37

+19.0%

NASDAQ · Mkt cap $5.0 M

No news headlines were found in the last 48 hours, so the 19% gain cannot be directly attributed to a specific announced event. The move may reflect technical trading, delayed news dissemination, or broader market sentiment toward the biotech sector.

MLEC is a precision fermentation and agricultural biotechnology company, and a 19% single-day jump without corresponding news in the provided feed is noteworthy. The absence of headlines in the last 48 hours does not rule out that news was published earlier or that a catalyst occurred but was not indexed by the feed yet. Another possibility is that the stock responded to broader sector momentum, short covering, or options-related buying pressure. Biotech stocks, particularly smaller-cap names, can experience outsized moves on thin volume or technical factors. Without headline confirmation, the specific trigger remains unclear, though sector sentiment or an announcement that has not yet propagated through major news outlets are plausible explanations.

HIVE

Aerohive Networks IncFinancial Services

$3.07+$0.49

+19.0%

NASDAQ · Mkt cap $820 M

HIVE surged 18.97% on announcement of a $350 million five-year GPU cloud services contract with an investment-grade customer, deploying 2,016 Nvidia Blackwell Ultra GPUs and adding approximately $70 million in annualized revenue.

The stock's sharp gains align directly with HIVE Digital's announcement of a major AI infrastructure deal signed on August 17. The contract represents a strategic shift for the company, traditionally known for Bitcoin mining, into the high-growth AI cloud services sector. The deal adds meaningful recurring revenue—roughly $70 million annually under a five-year commitment—and demonstrates the viability of HIVE's BUZZ HPC subsidiary and Bell AI Fabric facility in British Columbia. Multiple news outlets emphasized this positions HIVE closer to its $200 million annualized revenue target. The market's response reflects both the contract size and the strategic validation that a large, investment-grade customer is willing to commit significant capital to HIVE's GPU infrastructure, reducing execution risk around the company's AI infrastructure pivot.

DUOT

Duos Technologies Group IncTechnology

$10.27+$1.75

+18.9%

NASDAQ · Mkt cap $338 M

Duos Technologies surged 18.92% on announcement of five-year, $500+ million hosting agreements with Axe Compute for 55 MW of AI data center capacity, a deal worth over 18 times the company's 2025 revenue and marking a major commercial milestone in its AI infrastructure strategy.

The stock's sharp gain directly correlates with a same-day press release announcing multi-hundred-million-dollar long-term hosting agreements that represent a transformative contract for the company. The deal provides revenue visibility and scales Duos' AI data center footprint significantly. The headlines note the agreement value exceeds 18 times 2025 revenue, underscoring the magnitude relative to the company's historical size. Additionally, Duos reported Q2 2026 results showing nearly 30% revenue growth driven by AI and data center deployments and secured over $100 million in growth capital. The combination of a landmark long-term contract, strong quarterly performance, and capital secured appears to have driven investor enthusiasm about the company's transition into high-margin AI infrastructure operations.

FDMT

4D Molecular Therapeutics, Inc.Healthcare

$14.55+$2.31

+18.9%

NASDAQ · Mkt cap $812 M

No news headlines were found in the last 48 hours, so the 18.87% gain cannot be directly attributed to reported company-specific information, suggesting the move may stem from technical factors, delayed news, or market rumors.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to ground the explanation in a specific catalyst. For a small-cap biotech company like 4D Molecular Therapeutics, typical catalysts that drive such moves include clinical trial results, FDA decisions, partnership announcements, or licensing agreements. The stock's ranking as the 31st biggest gainer suggests either a broad market tailwind affecting biotech or a company-specific event that has not yet been widely covered in the headline feed checked. Without access to real-time trading data, social media, or company press releases beyond the provided news sources, attribution remains speculative. The move could reflect delayed publication of earnings or news, technical buying pressure, options-driven activity, or rumors circulating in biotech forums.

ARAY

Accuray IncHealthcare

$0.33+$0.05

+18.4%

NASDAQ · Mkt cap $35 M

No news headlines were found in the last 48 hours, so the 18.4% gain in ARAY shares likely reflects either a technical bounce, delayed market reaction to an older announcement, or untracked corporate activity.

Accuray Inc is a medical device company focused on radiosurgery and radiation therapy systems. The stock gained 18.4% on August 17 with no identifiable news in the prior 48 hours according to available sources. For a small-cap medical device stock trading at $0.33, typical catalysts include clinical trial results, FDA regulatory actions, contract wins, quarterly earnings, analyst upgrades, or institutional buying. The absence of headlines does not rule out these events occurring; it may indicate the news was not captured by Yahoo Finance RSS, broke after market close on August 16, or originated from a non-standard source. Another possibility is a delayed market reaction to older company announcements, insider activity, or technical factors such as short covering in a thinly traded security. Without access to real-time trading data or company filings from that specific date, the precise cause cannot be determined.

ACXP

Acurx Pharmaceuticals, Inc.Healthcare

$1.65+$0.25

+17.9%

NASDAQ · Mkt cap $6.2 M

Acurx Pharmaceuticals surged 17.92% following FDA conditional acceptance and USPTO trademark allowance for its lead antibiotic candidate ibezapolstat, a significant regulatory milestone for the late-stage biopharmaceutical company.

The headline establishes that Acurx announced two favorable regulatory developments on the day of the price jump: FDA conditional acceptance and a USPTO trademark allowance for ibezapolstat, the company's novel antibiotic targeting difficult-to-treat bacterial infections. For a late-stage biotech stock, FDA conditional acceptance represents meaningful progress toward potential commercialization and is a classic catalyst for equity appreciation. The trademark allowance, while secondary, reinforces the company's path to market by securing the brand name. The timing of the announcement at 12:01 UTC aligns directly with the trading session, making this a clear event-driven move. The stock's ranking as the 33rd biggest gainer suggests broader market recognition of the news rather than isolated retail activity.

AXTI

AXT IncTechnology

$95.91+$14.23

+17.4%

NASDAQ · Mkt cap $3.7 B

AXT Inc. shares surged 17.42% following a Taipei supply report indicating an imminent indium phosphide price hike, benefiting the company as a leading InP substrate manufacturer amid strong AI data-center demand.

The headlines establish a clear catalyst: a supply-side report from Taipei on indium phosphide pricing drove the move on August 17. AXT manufactures InP substrates, which are critical inputs for optics and semiconductor applications experiencing record demand from AI data centers. Multiple sources note that institutional investors appear to have positioned ahead of this announcement, suggesting the market anticipated a supply squeeze. The company's already-elevated valuation (48.12X) and year-to-date surge of 399% reflect prior recognition of these tailwinds, but the specific price-hike confirmation crystallized buying. A secondary factor is the launch of leveraged ETFs on AXTI, which could mechanically amplify share demand on institutional flows. The financial conference announcement is routine and unlikely to have driven the jump.

YYGH

YY Group Holding Limited Class A Ordinary SharesIndustrials

$1.42+$0.22

+16.9%

NASDAQ · Mkt cap $4.5 M

No news headlines were found in the last 48 hours to explain YYGH's 16.88% gain on August 17, 2026. The jump likely reflects technical trading, a delayed announcement, or sector rotation rather than a specific disclosed catalyst.

YY Group Holding Limited (YYGH) posted a significant single-day gain of 16.88%, ranking it among the day's top 35 gainers, yet no material news was published in the preceding 48 hours according to Yahoo Finance RSS feeds. This disconnect between price action and visible news suggests either that a catalyst emerged outside standard financial newswires, that the market reacted to older information, or that the move was driven by technical factors such as short covering, options expiration dynamics, or rotation into Chinese tech stocks. Without access to earnings reports, guidance changes, partnership announcements, or other specific corporate events, it is not possible to pinpoint the cause. YYGH, a live streaming and entertainment platform, could be sensitive to shifts in investor sentiment toward Chinese tech equities or to company-specific developments not yet reflected in major financial feeds.

GNPX

Genprex IncHealthcare

$4.47+$0.71

+16.6%

NASDAQ · Mkt cap $2.0 M

No news headlines were found in the last 48 hours, so the 16.55% gain likely reflects either a delayed market reaction to an earlier announcement, technical trading, or untracked company-specific developments.

Genprex Inc is a clinical-stage biotech company focused on gene therapy, a sector prone to both significant volatility and price swings driven by non-public communications, clinical trial updates, or regulatory interactions that may not immediately appear in tracked RSS feeds. The absence of Yahoo Finance headlines does not rule out that news was released or that institutional or insider knowledge of a positive development (such as trial progress, partnership discussions, or regulatory feedback) drove buying pressure. Biotech stocks of this size and stage frequently gap higher on catalysts that take time to propagate through financial media. Alternatively, the move could reflect technical buying, short covering, or broader sector rotation favoring smaller-cap gene therapy plays. Without confirmed reporting, the specific cause remains unclear.

CJMB

Callan JMB Inc. Common StockIndustrials

$2.66+$0.38

+16.5%

NASDAQ · Mkt cap $15 M

Callan JMB surged 16.51% on news that the company regained compliance with Nasdaq's minimum bid price requirement, lifting delisting risk and restoring investor confidence in the stock's continued exchange listing.

The headline directly addresses a compliance milestone: Callan JMB announced on August 17 that it has regained compliance with Nasdaq's minimum bid price rule, which requires listed companies to maintain a closing bid price above $1.00 per share for a sustained period. Failure to meet this requirement can trigger delisting proceedings. The stock's current price of $2.66 is well above the threshold, confirming the compliance status. For a stock trading near the delisting danger zone, regaining compliance removes an existential threat and eliminates uncertainty about continued listing eligibility. This regulatory clearance typically triggers relief buying and short-covering, as investors who had avoided the stock due to delisting risk can now re-enter. The 16.51% jump is proportionate to this type of de-risking event, particularly for a lower-priced stock where percentage moves are more volatile.

REBN

Reborn Coffee, Inc.Consumer Cyclical

$1.49+$0.21

+16.4%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 16.41% gain cannot be tied to a specific announced catalyst. The jump likely reflects technical trading, retail momentum, or undisclosed developments not yet picked up by Yahoo Finance.

The absence of any recent news in the Yahoo Finance RSS feed for Reborn Coffee within the past two days makes it difficult to establish a direct cause for the stock's substantial 16.41% single-day gain. This type of move in a micro-cap coffee company stock could reflect several common scenarios: a short squeeze or covering of a heavily shorted position, technical bounce off support levels attracting algorithmic or retail buying, a delayed reaction to news released outside the monitored news feed, or speculation ahead of unreported business developments. Alternatively, the move could stem from social media mention, insider activity, or other non-traditional signals that equity news aggregators may not capture immediately. Without access to real-time order flow or company disclosures beyond the provided headlines, confirming the catalyst remains speculative.

GTEC

Greenland Technologies HoldingConsumer Cyclical

$0.80+$0.11

+15.6%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours, so the 15.56% gain likely reflects technical trading activity, short covering, or an undisclosed development not yet captured in major financial news sources.

Greenland Technologies (GTEC) rose 15.56% to $0.80 with no corresponding news headlines available in the provided 48-hour window. This disconnect between price action and reported news is common for low-priced, lower-liquidity stocks where even small absolute volume shifts can produce large percentage moves. Possible explanations include technical bounce-back after prior weakness, short-squeeze activity if the stock carries a meaningful short position, an earnings release or company announcement that has not yet been indexed by the RSS feed, or institutional accumulation ahead of a known catalyst. Without access to Level 2 data, trading volume comparisons, or short interest metrics, the specific driver remains unclear.

NTHI

NEONC TECHNOLOGIES HOLDINGS, INC.Healthcare

$4.89+$0.65

+15.4%

NASDAQ · Mkt cap $120 M

No news headlines were found in the last 48 hours for NTHI, so the 15.4% gain likely reflects a technical bounce, delayed announcement pickup, or market speculation rather than a confirmed catalyst.

The absence of recent news headlines makes it difficult to pinpoint a specific event driving the jump. NTHI is a small-cap stock trading on NASDAQ, and such securities are often subject to technical bounces, short-covering rallies, or delayed news pickup from earlier announcements that may not have circulated widely through major news feeds. Without access to company filings, insider activity, or social media chatter that sometimes precedes retail-driven moves, the most probable categories are a technical rebound from oversold conditions, accumulation by informed traders ahead of expected announcements, or broader sector rotation into technology stocks. The stock's rank as the 40th biggest gainer suggests this was a notable move but not extraordinary in absolute terms, consistent with microcap volatility rather than a major fundamental shift.

FCUV

Focus Universal, Inc.Technology

$6.44+$0.86

+15.0%

NASDAQ · Mkt cap $5.7 M

No news headlines were found in the last 48 hours, so the 15% gain cannot be attributed to a specific announced event. The move likely reflects technical trading activity, delayed news dissemination, or market speculation.

Focus Universal is a small-cap NASDAQ stock with a 15% intraday surge but zero news coverage in the Yahoo Finance RSS feed over the past two days. This disconnect is typical for lower-liquidity names where price moves can be driven by technical factors, short covering, retail trading interest, or news that has not yet propagated through major news aggregators. Without headline confirmation, we cannot determine whether this reflects genuine fundamental news, a short squeeze, options-related gamma activity, or simply low-volume volatility. The absence of news does not rule out an announcement made through other channels or a catalyst already priced in by market participants before major outlets reported it.

CBRS

Cerebras Systems Inc.Technology

$251.88+$32.79

+14.9%

NASDAQ · Mkt cap $44 B

Cerebras surged 14.94% following announcements that its Wafer-Scale Engine hardware powers OpenAI's new GPT-5.6 Sol API Ultrafast mode, delivering 14x faster inference speeds, combined with analyst upgrades flagging a deeper partnership opportunity worth billions.

The jump is grounded in multiple converging catalysts announced on 2026-08-17. Cerebras disclosed that OpenAI is deploying its Wafer-Scale Engine processors in a new high-speed inference tier, with reported speedups of 14x versus standard processing. Wedbush research independently flagged this as evidence of a deepening partnership, estimating the deal opportunity could expand significantly beyond prior expectations. The CEO also reiterated strong AI market growth tailwinds and noted the company remains in early production ramp. Collectively these headlines suggest concrete customer validation, accelerating revenue trajectory, and analyst confidence in larger TAM capture. The stock had sold off sharply the prior week, so the news triggered both relief and technical recovery buying. Notably, the intraday peak of 19.2% occurred before the close, with the reported snapshot at 14.94%, suggesting some profit-taking into strength.

OABI

OmniAb, Inc.Healthcare

$3.82+$0.49

+14.8%

NASDAQ · Mkt cap $691 M

OmniAb announced a global collaboration and licensing agreement with Eli Lilly for an ion-channel drug discovery program and simultaneously raised its 2026 cash guidance, driving the 14.85% stock gain on licensing momentum and improved balance sheet outlook.

On August 17, 2026, OmniAb disclosed a multi-headline event: a named partnership with Eli Lilly (a major pharmaceutical company) on ion-channel drug discovery, coupled with a formal increase to 2026 financial guidance citing strengthened year-end cash position from recent technology licensing and business development activity. For a biotech company with a market cap implied by a $3.82 price point, a major pharma partnership represents both validation of its discovery technology platform and near-term cash inflow, reducing financing risk. The simultaneous guidance raise signals management confidence in revenue realization. The stock's 18% intraday peak and final 14.85% close align directly with these catalysts, which are concrete and material to a preclinical/early-stage biotech's valuation. No contradictory news or earnings misses are evident.

RCMT

RCM Technologies IncIndustrials

$40.20+$5.17

+14.8%

NASDAQ · Mkt cap $286 M

No relevant news about RCMT was provided; the 14.76% gain likely reflects a contract win, earnings beat, or technical bounce, but the specific catalyst cannot be confirmed from available headlines.

The news snippet provided only mentions OmniAb and Eli Lilly and is unrelated to RCM Technologies, a staffing and engineering services company. RCMT's sharp 14.76% gain ranks it among the day's top gainers, but no headline directly addresses the stock. RCM typically moves on contract acquisitions, headcount expansion announcements, margin improvements from better utilization rates, or broader staffing-sector sentiment shifts. The size and timing of this move suggests a material positive event rather than random drift, but without corroborating news, the catalyst remains unknown. It is possible the news simply has not yet been indexed by the RSS feed, or the move reflects pre-announcement accumulation or technical factors in a lower-liquidity name.

QSEAR

Quartzsea Acquisition Corporation

$0.25+$0.03

+14.3%

NASDAQ

No news headlines were reported in the last 48 hours, so the 14.31% gain cannot be tied to a specific announced catalyst; the move likely reflects either a delayed market reaction, technical trading activity, or undisclosed developments in a SPAC or shell company structure.

Quartzsea Acquisition Corporation is a SPAC (special purpose acquisition company) trading at $0.25 with no recent headlines in the provided news feed. The stock's significant intraday gain without accompanying news suggests several possible explanations. First, SPACs often exhibit sharp price movements tied to merger negotiations or deal announcements that may circulate as rumors before formal disclosure. Second, given the stock's very low price point, it may experience amplified percentage swings from modest absolute dollar volume shifts or short covering. Third, there could be a delayed market reaction to news not captured in the 48-hour window, or an off-market development announced through an 8-K or press release. Without specific headlines or structural context about pending business combinations or shareholder actions, the exact catalyst remains speculative.

BMM

Blue Moon Metals Inc.Basic Materials

$5.08+$0.69

+14.3%

NASDAQ · Mkt cap $544 M

No news headlines were published in the last 48 hours for Blue Moon Metals, so the 14.28% jump cannot be directly attributed to any disclosed event. The move likely reflects technical trading, delayed news pickup, or sector-wide momentum.

The absence of recent news headlines means we cannot point to a specific corporate announcement, earnings surprise, contract win, or regulatory action as the cause of today's 14.28% gain. For a metals company like BMM, typical catalysts that drive single-day moves of this magnitude include commodity price shifts, production updates, merger speculation, analyst upgrades, or short covering. Without evidence of any of these in the provided headlines, the move falls into the category of either technical rebound (possibly after oversold conditions), sector rotation into materials, or news that has not yet been indexed by the RSS feed or released after market open. It is also possible that a significant announcement was made but has not yet appeared in the Yahoo Finance feed lag window.

ACH

Aluminum Corp of China LtdHealthcare

$1.07+$0.13

+14.3%

NYSE · Mkt cap $102 M

Accendra Health abandoned an equity issuance plan and provided a CEO succession timeline update, both of which likely reduced dilution fears and signaled management stability, driving the 14.27% gain.

The two news items both relate to capital allocation and leadership continuity at Accendra Health. The company's decision to drop an at-the-market equity offering program removes the threat of near-term shareholder dilution, which typically pressures stock prices. Simultaneously, providing clarity on CEO succession timing reduces uncertainty about executive leadership. Together these moves suggest management is prioritizing shareholder value preservation and operational continuity over aggressive equity fundraising. For a small-cap stock trading at $1.07, both pieces of news are materially positive signals that warrant a meaningful single-day rally. The timing of both announcements on the same day amplified the positive sentiment.

UUU

Universal Security Instruments IncIndustrials

$3.94+$0.49

+14.2%

NYSE · Mkt cap $19 M

No news headlines were found in the last 48 hours, so the 14.22% jump cannot be attributed to a disclosed catalyst. The move likely reflects technical trading, a delayed announcement, or market speculation in a low-liquidity security.

Universal Security Instruments Inc experienced a significant single-day gain of 14.22% on August 17, 2026, ranking among the day's top gainers. However, no news headlines from the prior 48 hours are available to explain this move. For a small-cap stock trading at $3.94, price action of this magnitude can reflect various factors including short covering, options expiration dynamics, after-hours news not yet indexed by the RSS feed, or momentum trading on low volume. Without access to intraday trade volume, institutional positioning data, or company announcements made outside traditional news channels, determining the specific catalyst is not possible. The absence of news does not rule out a real event; it simply means the evidence needed to identify it is not available here.

AEI

Alset EHome International Inc.Real Estate

$1.51+$0.19

+14.2%

NASDAQ · Mkt cap $64 M

No news headlines were available in the last 48 hours, so the 14.18% gain on AEI likely reflects a technical rebound, delayed market reaction to an earlier announcement, or speculative trading activity in a low-priced stock.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for today's 14.18% rally in AEI. Alset EHome International is a micro-cap stock trading at $1.51, which makes it susceptible to technical bounces after declines, short covering, retail buying patterns, or delayed digestion of older announcements not captured in the 48-hour window. Stocks in this price range and market-cap bracket often move on low volume or broader sentiment shifts in the small-cap or China-focused stock sectors rather than company-specific catalysts. Without access to trading volume data, insider activity, or prior-day context, the specific driver remains unclear but falls into typical patterns for micro-cap volatility.

EHLD

Euroholdings Ltd.Industrials

$10.68+$1.29

+14.1%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 14.14% gain on EHLD cannot be attributed to a specific reported event. The move likely reflects technical buying, delayed news publication, or undisclosed market catalysts.

Yahoo Finance's RSS feed returned no headlines for EHLD in the 48 hours preceding the snapshot dated 2026-08-17. Without access to the company's news flow, earnings releases, regulatory filings, or market-moving announcements, we cannot definitively explain the jump from the provided sources. For a stock ranking as the 50th biggest gainer of the day with a 14.14% move, typical catalysts would include quarterly earnings beats or misses, analyst upgrades or downgrades, contract wins, regulatory approval or rejection, M&A activity, or short-squeeze dynamics. The absence of headlines in the provided data could indicate delayed syndication, a sudden after-hours development, or a purely technical/sentiment-driven move that has not yet been covered by major news outlets.

Biggest Losers

Mon, Aug 17, 2026 50

ZTG

Zenta Group Company LimitedIndustrials

$3.28−$7.15

-70.2%

NASDAQ · Mkt cap $30 M

ZTG collapsed 70% with no news headlines in the last 48 hours, making the specific trigger impossible to identify; the drop likely stems from a company announcement, earnings miss, regulatory action, or market-moving rumor not yet captured in available news feeds.

The absence of any headlines in the last 48 hours paired with a catastrophic 70% single-day decline is unusual and suggests either a significant gap between when the event occurred and when major news outlets reported it, or that the catalyst is still emerging. ZTG's extreme rank as the day's largest loser indicates this was not a broad market move. For a stock of this size and exchange listing, such a collapse typically reflects earnings that badly missed expectations, a sudden dilutive financing, executive departure, regulatory setback, or material restatement. Without access to the company's own press releases or financial announcements from today, we cannot confirm which category applies. It is also possible an announcement was made after market close yesterday or during pre-market trading this morning and has not yet propagated through standard financial news aggregators.

EYPT

EyePoint Pharmaceuticals IncHealthcare

$4.87−$9.90

-67.0%

NASDAQ · Mkt cap $459 M

EyePoint's lead wet AMD drug candidate DURAVYU failed to meet the primary endpoint in its Phase 3 LUGANO trial, triggering the 67% crash despite some positive secondary data and a non-inferior comparison in an ad hoc subgroup analysis.

The headlines establish a clear and direct cause: EyePoint announced topline results from the LUGANO Phase 3 trial on August 17, 2026, showing that DURAVYU missed its primary endpoint in the full trial population. This is a critical setback for the company because the drug was positioned as a potential breakthrough treatment for wet age-related macular degeneration, a major ophthalmology market. While the company reported positive secondary endpoints and demonstrated non-inferiority to the standard-of-care drug aflibercept in an ad hoc subgroup analysis excluding 9 patients with unrelated vision loss, the failure to meet the primary endpoint in the overall dataset is a regulatory and commercial red flag. The market interpretation appears to reflect the binary risk inherent in late-stage pharma: the primary failure substantially reduces the probability of FDA approval or market differentiation despite the mixed secondary signals.

AIFU

Fanhua Inc.Financial Services

$18.49−$18.30

-50.4%

NASDAQ · Mkt cap $74 M

No news headlines were found in the last 48 hours to explain Fanhua's 50.41% drop, making the specific catalyst unclear, though a significant market event or company announcement likely occurred.

The absence of any headlines in Yahoo Finance's RSS feed over the last 48 hours is notable given the severity of this move. A 50% single-day loss in a NASDAQ-listed company typically reflects either a major corporate event (earnings miss, guidance cut, management change, regulatory action) or a significant market catalyst. Fanhua is a Chinese education technology and online test preparation platform, so potential explanations could include adverse regulatory developments affecting Chinese edtech stocks, disappointing quarterly results, a material business setback, or broader selloff pressure on the sector. Without published headlines available, we cannot confirm which category of event drove the move. It is also possible the news was released through channels other than Yahoo Finance's RSS feed, or the information gap reflects a timing delay in news aggregation.

AACBR

Artius II Acquisition Inc. Rights

$0.01−$0.01

-45.6%

NASDAQ

No news headlines were found in the last 48 hours, so the 45.62% decline in AACBR rights cannot be directly attributed to a specific announced event. Rights offerings are volatile instruments sensitive to redemption activity and parent SPAC performance.

The absence of recent news makes it impossible to identify a concrete catalyst for today's sharp drop. However, AACBR is a rights offering tied to Artius II Acquisition Inc., a SPAC structure. Rights are inherently volatile and typically trade at minimal premiums to intrinsic value. Common causes of sharp declines in SPAC rights include deteriorating redemption sentiment around the parent company's merger prospects, investor exit from the SPAC position ahead of a merger vote or deadline, or simple illiquidity amplifying small-volume trades. The stock's already minimal price of $0.01 suggests the rights are trading near technical worthlessness, which can produce outsized percentage swings on tiny absolute price changes. Without access to current redemption rates, merger timing, or intraday volume data, the specific driver cannot be determined from the information provided.

FTRK

FAST TRACK GROUPCommunication Services

$0.16−$0.12

-42.1%

NASDAQ · Mkt cap $3.0 M

No news headlines were found in the last 48 hours, so the cause of the 42.15% drop cannot be directly attributed to a specific disclosed event. The move likely reflects technical selling, market liquidity constraints, or undisclosed company developments in a low-priced stock.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to an earnings miss, regulatory action, partnership announcement, or guidance revision as the cause. FTRK is trading at $0.16, placing it in the micro-cap or penny-stock category where price movements of this magnitude are not uncommon even on modest trading volume. Such stocks are sensitive to technical factors, short covering, retail sentiment shifts, and liquidity events. A 42% single-day drop could reflect sudden selling pressure from a large holder, a failed catalyst that was anticipated, or a delayed negative announcement that bypassed typical news channels. Without corroborating headlines, the most likely explanations are technical or involve information that has not yet been broadly reported.

NXGL

NexGel, Inc Common StockHealthcare

$0.38−$0.19

-33.0%

NASDAQ · Mkt cap $3.7 M

NexGel reported Q2 2026 revenue of $3.69 million with a net loss, and the BioNX integration is facing slower-than-expected ramp, triggering the 33% single-day sell-off as the sixth biggest loser on the day.

NexGel released second-quarter 2026 earnings on August 17, 2026, disclosing revenue of $3.69 million alongside a net loss. The headline specifically flags that BioNX integration, presumably a recent acquisition or partnership, is facing a slower ramp than anticipated. This suggests management underperformed on a key integration milestone that investors were likely relying on for near-term revenue growth and path to profitability. The combination of modest absolute revenue, continued losses, and a significant slowdown in a material growth driver typically triggers sharp selloffs in small-cap healthcare and beauty companies where investor expectations hinge on operational acceleration. The magnitude of the decline reflects the stock's likely low liquidity and high beta to disappointment.

GIPR

Generation Income Properties Inc.Real Estate

$0.34−$0.15

-31.0%

NASDAQ · Mkt cap $253 K

Generation Income Properties announced improved Q2 results and restored Nasdaq compliance, yet the stock fell 31% the same day, suggesting the market either expected stronger performance or has concerns that outweigh the positive headlines.

The company released earnings and shareholder updates on August 17 showing a 76% year-over-year reduction in net loss and restoration of Nasdaq stockholders' equity compliance, both materially positive developments. However, the stock declined sharply instead of rallying, which indicates the market's reaction was not driven by headline relief. The disconnect suggests either the earnings details, operational metrics, or forward guidance in the full announcement disappointed relative to investor expectations, or that pre-existing bearish sentiment on the stock (common for micro-cap income properties companies) overcame the positive narrative. Without access to the complete earnings release content, guidance, or analyst sentiment, the precise reason for the selloff cannot be isolated.

BRFH

Barfresh Food Group Inc.Consumer Defensive

$1.33−$0.59

-30.7%

NASDAQ · Mkt cap $21 M

No news headlines were available in the last 48 hours, so the 30.73% drop cannot be attributed to a specific announced event. The decline likely stems from technical selling, broad market weakness, or unannounced company developments.

Barfresh Food Group is a small-cap beverage company trading on NASDAQ, and the absence of recent news headlines makes it impossible to pinpoint a concrete catalyst for the sharp 30.73% single-day decline. Small-cap stocks of this size often experience outsized moves on modest trading volume and can be sensitive to technical factors, margin calls, or shifts in sector sentiment. The stock's low price point and likely limited institutional coverage mean material information sometimes disseminates through channels other than major financial news feeds, or moves may reflect internal developments not yet publicly disclosed. Without access to company filings, insider transactions, or industry-specific reporting from the snapshot date, the true driver remains opaque.

AIHS

Senmiao Technology LtdIndustrials

$1.56−$0.47

-29.9%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours to explain AIHS's 29.94% single-day drop, making the precise cause unclear without additional information about market conditions or company developments.

The absence of any news headlines in the last 48 hours is notable given the severity of the decline, ranking AIHS as the ninth biggest loser on the day. For a micro-cap stock like Senmiao Technology, possible explanations include a delayed negative announcement not yet picked up by Yahoo Finance RSS feeds, a significant intraday technical breakdown or stop-loss cascade, sector-wide weakness in transportation or financial services stocks that AIHS operates in, short-seller activity or a research report, insider selling, or broader market volatility spillover. Without corroborating headlines or structural knowledge about imminent catalysts specific to this company, determining whether this is a fundamental repricing or a technical event remains speculative.

PROP

Pledge Petroleum Corp.Energy

$0.71−$0.30

-29.7%

NASDAQ · Mkt cap $69 M

Prairie Operating Co. (ticker PROP) reported strong Q2 2026 earnings with 45% year-over-year revenue growth and net income of $193.8 million, yet the stock fell 29.71%, suggesting the market either expected significantly better results or reacted to forward guidance concerns not detailed in the h…

The company announced Q2 2026 results showing headline revenue of $98.9 million (up ~45% YoY) and substantial net income of $193.8 million, alongside production growth to 21,866 Boe/d. On the surface, these appear to be positive metrics that would typically support stock appreciation rather than a 30% single-day decline. However, the provided headlines are incomplete excerpts that do not include forward guidance, margin commentary, debt position, capital allocation announcements, or management's outlook statements. Energy stocks commonly react sharply to production or reserve guidance misses, reserve write-downs, debt covenant concerns, dividend cuts, or disappointing guidance despite current-quarter strength. Without access to the full earnings call transcript or detailed guidance revisions, the precise catalyst remains unclear, though earnings-related disappointment (guidance, commentary, or underlying metrics not shown in these snippets) is the most probable category.

BEAGR

Bold Eagle Acquisition Corp. Right

$0.24−$0.09

-27.7%

NASDAQ

No news headlines were found in the last 48 hours, so the 27.68% drop likely stems from technical selling, SPAC-specific risks, or broader market conditions affecting low-priced acquisition vehicles rather than a discrete announced catalyst.

Bold Eagle Acquisition Corp. Right is a SPAC rights unit, a security type that typically trades on sentiment around the underlying acquisition target and merger timeline rather than operational news. The absence of any news in the last 48 hours rules out earnings, guidance, or deal announcements as the immediate cause. The sharp single-day loss in a low-priced SPAC component suggests either profit-taking after a recent run, a broader selloff in blank-check securities, redemption pressure ahead of a merger vote, or technical support breaks in illiquid securities. SPACs and their constituent units (common, warrant, and right) are prone to sharp moves on low volume and sentiment shifts unrelated to named catalysts. Without access to trading volume, short interest, or merger status updates, the exact mechanism remains unclear, though SPAC-specific structural risks are the most likely explanation for a day-specific move of this magnitude.

TONT.WT

Graf Global Corp.

$0.36−$0.13

-26.5%

BALY

Bally's CorporationConsumer Cyclical

$10.35−$3.64

-26.0%

NYSE · Mkt cap $446 M

Bally's plunged 26% after issuing a going concern warning due to liquidity problems triggered by a construction pause at its flagship $1.7 billion Chicago casino project, compounded by a heavy debt load of approximately $4.5 billion.

The headlines establish a direct and concrete cause: Bally's halted construction on most non-gaming amenities at its River West Chicago casino and subsequently issued a formal going concern warning, signaling material doubt about the company's ability to continue operations. Going concern warnings are severe red flags that typically trigger sharp sell-offs because they indicate potential insolvency or restructuring risk. The company appears to have hit a liquidity crisis precisely when it has massive capital commitments tied up in the Chicago project and carries billions in debt. The construction slowdown suggests either project financing problems or operational cash flow deterioration. With $4.5 billion of debt outstanding and a stalled major development, investors face real questions about debt refinancing, covenant compliance, and equity value preservation. The timing and magnitude of the stock decline (26-31% in a single session) aligns precisely with the severity of a going concern statement.

CTXR

Citius Pharmaceuticals IncHealthcare

$0.56−$0.20

-25.8%

NASDAQ · Mkt cap $18 M

Citius Pharmaceuticals dropped 25.76% with no news reported in the last 48 hours, making the specific catalyst unclear and likely driven by technical selling, sector weakness, or undisclosed market developments.

No headlines were identified in the Yahoo Finance RSS feed for the last 48 hours surrounding this sharp decline. For a micro-cap biopharmaceutical stock like Citius, large single-day moves without visible news catalyst can stem from several sources: clinical trial setbacks or delays announced through other channels, sector-wide pressure on small-cap biotech equities, profit-taking after a prior run-up, short-covering reversals, or deterioration in broader market sentiment toward speculative healthcare names. Without access to company filings, press releases beyond the RSS feed window, or technical context on prior price levels, attributing this move to a specific event would be speculation. The absence of reported news within 48 hours is notable but does not rule out an announcement made earlier or a delayed market reaction to previously disclosed information.

BTAI

Bioxcel Therapeutics IncHealthcare

$0.89−$0.29

-24.6%

NASDAQ · Mkt cap $26 M

No headlines were found in the last 48 hours to explain BTAI's 24.57% drop, suggesting the move may be driven by delayed news, technical selling, or broader biotech sector pressure rather than an identified company-specific catalyst.

The absence of recent news headlines makes it difficult to pinpoint a specific cause for this sharp decline. Biotech stocks of this type often experience significant moves on clinical trial results, FDA decisions, financing announcements, or changes in cash runway expectations, but none of those events are documented in the provided headlines. The timing lag between a news event and its appearance in RSS feeds could mean an announcement was made but not yet captured, or the sell-off could reflect technical momentum, sector-wide biotech weakness, or market-wide volatility. Without additional context about BTAI's financial position, pipeline stage, or recent insider activity, the most likely categories are either a delayed public announcement not yet reflected in the headline feed, or systematic selling pressure unrelated to company-specific fundamentals.

PMAX

Powell Max Limited Class A Ordinary SharesFinancial Services

$1.17−$0.38

-24.5%

NASDAQ · Mkt cap $2.1 M

No news headlines were available in the last 48 hours to explain PMAX's 24.52% drop on August 17, 2026. The sharp decline likely reflects either delayed news dissemination, technical selling, or an undisclosed corporate event.

The absence of any Reuters, Bloomberg, or Yahoo Finance headlines in the 48-hour window preceding this steep intraday drop makes it difficult to identify a specific catalyst. A 24.52% single-day loss for a low-priced stock like PMAX typically correlates with material adverse news—earnings misses, insider selling disclosures, regulatory action, or contract losses—but none appears in the available feed. It is possible that news broke after the RSS snapshot was taken, that the stock reacted to a filing accessible only through SEC Edgar, or that investor repositioning or short covering occurred on technical levels. Without additional context about PMAX's business model, recent financial performance, or insider activity, attribution remains speculative.

AUID

Ipsidy Inc.Technology

$0.40−$0.13

-24.2%

NASDAQ · Mkt cap $7.0 M

Ipsidy Inc. dropped 24.21% on August 17 with no material news disclosed in the past 48 hours, suggesting the move may reflect technical selling, delayed market reaction to prior events, or undisclosed corporate developments.

No headlines were identified in the Yahoo Finance RSS feed for the last 48 hours covering Ipsidy Inc., so the direct cause of the 24.21% decline cannot be attributed to a specific announced event. For a micro-cap security trading at $0.40, price swings of this magnitude often reflect thin liquidity, retail trading patterns, or delayed market reactions to prior press releases or regulatory filings that may not be prominently indexed by mainstream financial news aggregators. Possible categories of catalyst include adverse earnings or guidance, capital raises that dilute existing shareholders, reverse splits or other corporate actions, insider selling signals, or short-seller activity targeting low-float stocks. Without access to SEC filings, company press releases, or contemporaneous trading data, the specific trigger remains unknown.

CISS

C3is Inc. - Common StockIndustrials

$0.06−$0.02

-23.0%

NASDAQ · Mkt cap $4.6 M

C3is announced a reverse stock split effective August 19, 2026, to meet Nasdaq's minimum bid price requirement. The stock dropped 23% ahead of the split, likely reflecting investor concern about dilution, delisting risk, or the company's financial distress signaled by the need for the action.

The headline confirms a reverse stock split announcement with an effective date two days after the snapshot. Reverse splits are typically undertaken by companies trading below exchange minimum bid prices, signaling financial distress or inability to maintain listing standards. While the announcement itself does not disclose the split ratio, historical patterns show that reverse splits often trigger sharp declines in the pre-split period as investors digest the implications. The 23% drop is consistent with market pessimism about the company's fundamental condition, as reverse splits are rarely viewed as positive corporate actions. Investors may also be concerned about execution risk, further dilution through future capital raises, or accelerated delisting timelines if the company cannot sustain compliance afterward. The stock's extremely low price of $0.06 prior to the split underscores the severity of the listing challenge.

VWAV

VisionWave Holdings, Inc.Industrials

$1.43−$0.42

-22.7%

NASDAQ · Mkt cap $36 M

No news headlines were found in the last 48 hours, so the 22.73% decline cannot be directly attributed to a specific announced event. The drop likely reflects either a delayed market reaction to prior news, technical selling pressure, or sector-wide deterioration in a micro-cap stock.

VisionWave Holdings is a micro-cap NASDAQ stock with no headlines published in the last two days to explain the sharp 22.73% sell-off that ranks it among the day's biggest losers. Without news context, the cause could fall into several categories: a delayed market reaction to older news not captured in the 48-hour window, technical breakdown in a low-liquidity name, broad sector rotation out of technology or similar holdings, short covering reversing a prior squeeze, or an unannounced corporate event not yet reflected in public reporting. Micro-cap stocks often exhibit volatile moves on light volume driven by algorithmic rebalancing or institutional positioning rather than fundamental catalysts. The absence of any headline footprint is itself notable and limits confidence in causal attribution.

CURI

CuriosityStream Inc.Communication Services

$2.95−$0.76

-21.3%

NASDAQ · Mkt cap $173 M

No news headlines were published about CURI in the last 48 hours, so the 21.35% drop cannot be directly attributed to a specific announcement or event based on available information.

CuriosityStream is a digital streaming subscription service, and a drop of this magnitude on a stock ranked in the top 20 losers typically suggests either a material company-specific event, broad sector weakness in streaming stocks, or significant technical selling. Without news in the past 48 hours, the catalyst could fall into several categories: delayed disclosure of negative results or guidance that moved overnight or premarket, executive departures or leadership changes, subscriber or financial metrics deteriorating enough to trigger automatic selling algorithms, competitive pressures in the streaming space affecting the entire sector, or shifts in investor sentiment toward smaller subscription platforms. Streaming companies are particularly sensitive to subscriber growth, churn rates, and cash burn dynamics, any of which could have triggered institutional reallocation. A 21 percent single-day move also raises the possibility of a technical breakdown after support was breached, which can accelerate selling if volume was present.

IRHOR

Iron Horse Acquisitions Corp. II Rights

$0.15−$0.04

-21.1%

NASDAQ

No news headlines were found in the last 48 hours to explain the 21% drop in Iron Horse Acquisitions Corp. II Rights, so the cause is unclear without access to broader market or company-specific data.

Iron Horse Acquisitions Corp. II Rights is a SPAC rights offering, a structure that can be volatile and sensitive to shifts in sentiment toward blank-check companies, the broader merger and acquisition environment, or redemption pressure ahead of a merger deadline. Rights offerings are inherently leveraged instruments that amplify moves in the underlying warrant or acquisition story. Without any news headlines in the last 48 hours, the decline could stem from several categories: deterioration in confidence around an announced target, expiration or redemption dates approaching, broader SPAC market weakness, a failed merger announcement, or technical/liquidity-driven selling. The significant rank as the 21st biggest loser suggests this was a broad market condition rather than an isolated single-stock event. Without specific headlines or company announcements, pinpointing the exact trigger is not possible from the evidence provided.

LTCH

Latch, Inc.Technology

$0.15−$0.04

-20.8%

NASDAQ · Mkt cap $31 M

No news headlines were available in the last 48 hours to explain the 20.79% drop in LTCH stock, so the cause remains unclear without additional information.

Latch Inc. experienced a significant one-day decline of over 20 percent with no corresponding news headlines captured in the past two days. This disconnect suggests either the catalyst occurred outside the tracked news window, market reaction to industry trends or technical factors unrelated to company-specific announcements, or delayed market response to earlier developments. For a small-cap proptech company like Latch, typical drivers of sharp moves include quarterly earnings surprises, cash runway concerns, partnership announcements or losses, shifts in real estate market sentiment affecting smart lock demand, or broader fintech sector selloffs. Without headline evidence, determining whether this was fundamental (operational setback, guidance miss) or technical (momentum reversal, position unwinding) in nature is not possible from available data.

CXAI

Cxapp IncTechnology

$0.09−$0.02

-20.5%

NASDAQ · Mkt cap $10 M

CXAI fell 20.53% on August 17 with no news headlines in the prior 48 hours, making the specific catalyst unclear; the drop likely reflects either a delayed market reaction to an earlier announcement, technical selling pressure, or broader sector headwinds.

No recent headlines are available in the Yahoo Finance RSS feed for the past 48 hours surrounding this sharp single-day decline, so we cannot point to a specific earnings release, regulatory action, guidance change, or corporate event as a confirmed cause. CXAI trades at a low price point of $0.09, which suggests it may be a micro-cap or penny stock subject to higher volatility and potentially thinner liquidity. For stocks in this category, large single-day moves can reflect delayed reactions to news released more than 48 hours prior, technical breakdown of support levels, short covering or selling pressure from retail traders, or sector-wide sentiment shifts in its category. Without access to news beyond the provided 48-hour window or details on the company's fundamentals, operations, or recent corporate calendar, pinpointing the precise trigger is not possible from the available evidence.

SKYH.WT

Sky Harbour Group Corporation

$0.27−$0.07

-20.0%

SCKT

Socket Mobile IncTechnology

$0.92−$0.23

-20.0%

NASDAQ · Mkt cap $5.6 M

No news headlines were found in the last 48 hours, so the 20% drop in Socket Mobile stock on August 17, 2026 cannot be directly attributed to a specific announced event based on available information.

Socket Mobile is a small-cap hardware and software company in the mobile data capture space, and the absence of news headlines makes it difficult to pinpoint the precise catalyst. Small-cap stocks of this type are typically sensitive to shifts in investor sentiment, sector rotation, technical support breaks, and liquidity events that may not be accompanied by immediate press releases. The 20% single-day decline could reflect delayed market reaction to an unannounced earnings miss, a downgrade from an analyst covering the stock, weakness in the broader mobile hardware or retail technology sector, or a forced liquidation or rebalancing by a major shareholder. Without access to intraday trading data, SEC filings, or analyst calls that occurred within the window, the specific trigger remains unknown.

APACR

StoneBridge Acquisition II Corporation Rights

$0.08−$0.02

-19.9%

FTK

Flotek Industries IncEnergy

$28.66−$7.04

-19.7%

NYSE · Mkt cap $860 M

Wolfpack Research alleged cancellation of a major deal worth 57% of Flotek's near-term backlog, triggering the stock's worst day in over six years and prompting short positioning by the research firm.

A short-seller report from Wolfpack Research flagged the cancellation of a significant contract representing approximately 57% of Flotek Industries' near-term backlog. This type of allegation directly undermines investor confidence in revenue visibility and near-term growth prospects, explaining the severe sell-off. The fact that this contract was material to the company's forward pipeline means its loss creates a substantial earnings and cash flow headwind. Wolfpack's simultaneous short position adds credibility to the claim and signals they believe further downside is likely. The 19.72% single-day decline and characterization as the worst day in over six years indicate the market treated this as a material and credible threat to the investment thesis. Without access to Flotek's official response or independent verification of the deal cancellation, the exact circumstances remain Wolfpack's assertion, but the market has clearly priced in significant concern about the backlog claim.

FLYX.WT

flyExclusive, Inc.

$0.12−$0.03

-19.5%

DFSC

DEFSEC Technologies Inc.Industrials

$2.17−$0.55

-19.2%

NASDAQ · Mkt cap $5.8 M

DEFSEC announced a CAD$5.54 million private placement, which typically dilutes shareholder value and often triggers selling pressure on small-cap stocks, particularly when the offering price and terms are seen as unfavorable.

The company announced a private placement of 1,951,219 common shares totaling CAD$5.54 million. For small-cap stocks trading at low prices, equity offerings are frequently met with negative market reactions due to immediate shareholder dilution and the signal that management may be raising capital at an inopportune time or weak valuation. The 19.23% single-day drop is consistent with this type of announcement. The headline does not provide the offering price per share or use-of-proceeds details, which limits ability to assess whether dilution was severe or the capital raise was strategically justified. Without knowing the subscription price relative to DFSC's pre-announcement trading level, we cannot definitively quantify the dilution impact, though the magnitude of the price decline suggests the market viewed the terms unfavorably or the timing as poor.

INV

Innventure IncFinancial Services

$1.39−$0.31

-19.0%

NASDAQ · Mkt cap $112 M

INV dropped 19% with no news headlines in the last 48 hours, suggesting the catalyst was either a delayed market reaction to an earlier announcement, a technical or sentiment-driven sell-off, or an untracked event outside the provided news feed.

No headlines from Yahoo Finance RSS in the last 48 hours are available to explain INV's sharp 19% decline on August 17. This absence of reported news makes direct attribution impossible. For a small-cap biotech or development-stage company like Innventure, typical catalysts for large single-day drops include disappointing trial results, regulatory setbacks, clinical hold notices, failed partnerships, insider selling disclosures, or delayed negative announcements that circulated on specialized channels before reaching mainstream financial media. The magnitude of the move suggests a material negative event rather than routine volatility. Without access to company filings, press releases, or industry-specific news sources, the specific cause remains unknown, though the timing as the 30th biggest loser indicates broad market participation in the decline rather than isolated weakness.

RFAI

RF Acquisition Corp II Ordinary SharesFinancial Services

$8.94−$2.07

-18.8%

NASDAQ · Mkt cap $93 M

No news headlines were found in the last 48 hours, so the 18.8% decline cannot be attributed to a specific announced event; the drop is likely driven by technical selling, broader market conditions, or unreported developments specific to RFAI or its merger target.

RF Acquisition Corp II is a SPAC (special purpose acquisition company), and these vehicles are particularly sensitive to shifts in investor sentiment, redemption activity, and changes in merger deal dynamics. The absence of any news in the last 48 hours suggests the decline was not triggered by a public announcement. For SPACs, typical catalysts for sharp moves include redemption announcements, merger deal terminations or renegotiations, changes in deal valuation or timeline, insider redemptions, or broader liquidity conditions affecting blank-check companies. It is also possible that a relevant announcement was made but has not yet been captured in the financial news feeds provided, or that selling pressure reflects accumulated concerns about deal economics or execution risk that emerged over a longer timeframe.

CUE

Cue Biopharma IncHealthcare

$27.79−$6.37

-18.6%

NASDAQ · Mkt cap $175 M

No news headlines were found in the last 48 hours to explain the 18.64% drop in CUE, so the cause remains unclear without access to broader market context or real-time data from the past two days.

Cue Biopharma is a clinical-stage biopharmaceutical company focused on immuno-oncology, and biotech stocks of this profile typically move on clinical trial results, regulatory decisions, funding announcements, or shifts in competitive positioning. The absence of any news in the Yahoo Finance RSS feed over the last 48 hours is notable but does not rule out material developments; it is possible that news was published through other channels, that market-moving information emerged intraday, or that the sell-off reflects a delayed market reaction to an earlier announcement. A second-tier possibility is broad-market weakness affecting smaller-cap biotech disproportionately, though the 18.64% single-stock loss suggests something more company-specific. Without access to the full news universe or intraday developments, the specific trigger cannot be identified.

ONMD

OneMedNet CorpHealthcare

$0.62−$0.14

-18.4%

NASDAQ · Mkt cap $35 M

No news headlines were found in the last 48 hours, so the 18.44% drop cannot be attributed to a specific company announcement. The decline is likely driven by technical selling, broader market weakness, or an undetected catalyst not yet covered by major financial news feeds.

With no recent news available from Yahoo Finance RSS, the cause of OneMedNet's sharp 18.44% decline remains unclear from public headlines alone. For micro-cap and small-cap stocks like ONMD trading at $0.62, price movements of this magnitude can be triggered by several factors: deterioration in sentiment around unprofitable or pre-revenue healthcare IT companies, sector-wide pullbacks in digital health or medical software stocks, accumulation of insider selling or dilution from secondary offerings that may not trigger immediate headline coverage, or simple technical breakdown from breakdown of support levels that prompts algorithmic or momentum-driven selling. It is also possible that news moved the stock in the preceding day and carried into today, or that a material development was announced through channels not yet indexed by the RSS feed used here. Without specific company-level news, assigning causation requires inference rather than fact.

ENVX

Enovix CorporationIndustrials

$3.60−$0.81

-18.3%

NASDAQ · Mkt cap $740 M

Enovix's CEO Raj resigned effective immediately and was replaced by CFO Ryan Benton as interim CEO, a leadership vacuum that triggered an 18.3% sell-off despite management's assurance that strategy and product roadmap remain unchanged.

The two news items both broke on August 17, 2026 and describe the same event: the resignation of CEO Raj and the appointment of CFO Ryan Benton as interim CEO, with T.J. Rodgers elevated to Executive Chairman. While Enovix's management statement emphasizes that strategy, product roadmap, customer programs, and qualification schedules remain unchanged, unexpected CEO departures typically trigger sharp sell-offs in smaller-cap companies, particularly in the battery and semiconductor space where execution risk is high and investor confidence in specific leadership often matters significantly. The market appears to have interpreted the sudden change as a material negative signal about either performance, strategic direction, or internal tensions, despite the company's reassuring language. The lack of forward guidance updates or specific performance catalyst makes this a straightforward leadership transition event rather than a results miss or contract loss.

RKDA

Arcadia Biosciences IncConsumer Defensive

$0.49−$0.11

-18.2%

NASDAQ · Mkt cap $964 K

No news headlines were available in the last 48 hours to explain RKDA's 18.18% drop, so the cause remains unclear without access to broader market data, company announcements, or analyst activity.

The absence of any Yahoo Finance headlines in the past 48 hours means we cannot point to a specific catalyst such as earnings, FDA decision, clinical trial results, or guidance revision. RKDA is a small-cap biotech company, and stocks in this category often experience sharp moves on thin volume driven by several possible mechanisms: unexpected clinical or regulatory setbacks not yet widely reported, sector rotation out of biotech, technical breakdown of chart support, short covering reversals, or delayed disclosure of news from investor calls or SEC filings. Without access to real-time trading data, insider transactions, or broader sector indices for the snapshot date, pinpointing the precise trigger is not feasible from the information provided.

GYGY

Game Your Game, Inc.Technology

$1.93−$0.42

-17.4%

NASDAQ · Mkt cap $25 M

No news headlines were available in the last 48 hours, so the 17.36% drop cannot be attributed to a specific announced event; the cause likely stems from technical selling, broad market moves, or untracked developments.

Game Your Game Inc. (GYGY) experienced a sharp 17.36% decline on August 17, 2026, ranking as the 36th biggest loser of the day on NASDAQ. However, no news headlines were found in the Yahoo Finance RSS feed for the prior 48 hours, which means no earnings announcement, guidance change, regulatory action, acquisition news, or other major corporate event appears to have been publicly announced in that window. Without identifying information, the decline could reflect several common catalysts for micro-cap stocks: sudden technical selling or momentum reversal, broad market weakness on the day, a delayed press release not yet indexed by RSS feeds, short-covering triggering stops, or sector-specific headwinds in gaming or entertainment. Without access to real-time news, social media discussion, or intraday volume data, pinpointing the specific trigger is not possible from the evidence at hand.

RIME

Algorhythm Holdings, Inc.Technology

$0.31−$0.07

-17.4%

NASDAQ · Mkt cap $4.9 M

No news headlines were published in the last 48 hours for RIME, so the 17.36% decline cannot be directly attributed to a specific company announcement or market event based on available evidence.

The absence of any headlines in the past 48 hours means we cannot point to an earnings miss, guidance cut, regulatory action, or other named catalyst. Given that RIME trades at $0.31 and is ranked among the day's largest percentage losers, the move is more likely driven by one of several common causes in micro-cap stocks: technical selling pressure, a delayed or overnight news release not yet indexed by Yahoo Finance, short-covering or short-selling activity, sector rotation, or broader market conditions affecting low-priced equities. Penny stocks and nano-cap securities often exhibit large percentage swings on relatively modest trading volume shifts. Without headline evidence, we cannot distinguish between these possibilities.

GPUS

Hyperscale Data, Inc.Industrials

$0.09−$0.02

-17.3%

NYSE · Mkt cap $31 M

Alset AI announced the sale of a 9.9% stake in Lyken AI Computing to FingerMotion for US$500,000 in stock, implying a US$5M equity valuation for Lyken, which likely signaled disappointing value or strategic retreat to GPUS shareholders.

The headlines show that Alset AI Ventures Inc. (listed as TSXV:GPUS) completed a sale of its minority stake in Lyken AI Computing to FingerMotion Inc. on August 17, 2026. The transaction involved FingerMotion paying US$500,000 in FNGR shares, with the deal implying only approximately US$5M total equity value for Lyken based on the transaction price. For a company positioned in the enterprise AI compute market, a valuation of US$5M for the underlying asset and the decision to divest rather than hold or increase exposure may have disappointed investors expecting stronger growth or a higher-valued exit. The timing and structure suggest Alset prioritized liquidity over upside participation, which could signal either financial pressure or a vote of no confidence in Lyken's near-term prospects.

SKYE

Skye Bioscience, Inc.Healthcare

$0.42−$0.09

-17.2%

NASDAQ · Mkt cap $13 M

Skye Bioscience announced a merger with Redx Pharma to pivot toward fibrosis-focused therapeutics, offering shareholders a 5.4% stake in the combined entity plus a contingent value right, which likely disappointed investors expecting better terms or a more accretive deal structure.

The earnings call highlights reveal a material strategic transaction: a merger creating a fibrosis-focused company with Skye shareholders receiving a 5.4% stake and a contingent value right tied to Nimacimab monetization. The 17% drop suggests investor concern about deal valuation, dilution, or execution risk. A 5.4% stake post-merger implies significant dilution to current shareholders. The reliance on a contingent payment for upside introduces uncertainty and may signal the acquirer is pricing in lower near-term revenue visibility. Without the full merger terms, debt assumptions, or competing bid context, it is difficult to quantify whether the deal is clearly unfavorable, but the market reaction points to shareholder value concerns rather than enthusiasm for the strategic combination.

DDC

DDC Enterprise LimitedConsumer Defensive

$0.55−$0.11

-17.2%

NYSE · Mkt cap $27 M

No news headlines were found in the last 48 hours for DDC, so the 17.15% drop likely stems from technical selling, broader market movement, or an unannounced development not yet reflected in major financial news feeds.

The absence of any recent news headlines makes it impossible to identify a specific catalyst for DDC's sharp 17% decline on August 17, 2026. When a micro-cap stock moves this dramatically without accompanying news coverage, the cause typically falls into one of several categories: technical selling or profit-taking following a prior rally, broader market correction affecting small-cap or speculative names, delayed announcement or earnings miss not yet syndicated widely, a private rumor circulating in retail trading channels, or simply low liquidity amplifying normal trading volatility. Without access to company filings, insider transactions, or real-time trading volume data, any specific claim would be speculation. The rank as the 40th biggest loser suggests this is a real move amid broader market activity rather than isolated noise.

KRSP.WT

$0.91−$0.19

-16.9%

PEW.WT

GrabAGun Digital Holdings Inc. WT

$0.33−$0.07

-16.9%

GENVR

Gen Digital Inc. Contingent Value Rights

$2.85−$0.57

-16.7%

NASDAQ

GENVR fell 16.67% on the ex-dividend date for Gen Digital's $0.13 per share dividend, a mechanical price adjustment typical when contingent value rights trade without dividend protection.

The only headline provided announces a dividend payment and ex-dividend date of 2026-08-17, which is precisely the snapshot date of this price move. GENVR is a contingent value right (a claim on deferred consideration from a prior Gen Digital transaction), and such securities typically do not receive dividend adjustments—meaning the underlying stock price falls by the dividend amount on the ex-date, but CVR holders receive no cash payment. The 16.67% drop approximates the dividend as a percentage of the current CVR price, consistent with this mechanical effect. No other news, earnings announcements, or corporate developments are evident in the provided headlines.

CTOR

Citius Oncology, Inc.Healthcare

$0.77−$0.15

-16.5%

NASDAQ · Mkt cap $80 M

Citius Oncology shares fell 16.49% following a Q3 revenue miss despite momentum from the LYMPHIR launch, signaling investor disappointment with near-term commercial execution versus growth expectations.

The headline establishes that Citius Oncology reported Q3 revenue that fell short of forecasts. This is a classic earnings disappointment catalyst for small-cap biotech stocks, where investors often build high expectations around pipeline launches like LYMPHIR. The fact that the headline acknowledges "launch momentum" but still frames this as a miss suggests the company's revenue growth or absolute numbers came in below consensus estimates. For oncology-focused biotechs, a revenue shortfall despite a new product launch typically triggers a sharp repricing downward because it raises questions about market adoption, pricing power, and the durability of the growth narrative. The 16.49% single-day decline is proportional to what investors in pre-profitability or early-revenue biotech firms experience when earnings expectations reset lower.

CLDI

Calidi Biotherapeutics IncHealthcare

$1.37−$0.26

-16.3%

NYSE · Mkt cap $3.4 M

No news headlines were found in the last 48 hours, so the 16.25% drop cannot be tied to a specific announced event; biotech stocks of this scale often react to clinical trial setbacks, financing announcements, or market-wide biotech weakness that may not immediately appear in major RSS feeds.

The absence of any recent news in the provided RSS data makes it impossible to pinpoint a concrete catalyst for CLDI's sharp decline. However, this type of move in a small-cap biotech stock typically correlates with one of several common triggers: negative clinical trial results, a planned financing at an unfavorable price, insider selling, sector-wide biotech volatility, or delayed disclosures that surface through alternative channels before traditional headlines. Given CLDI's position as the 45th biggest loser on the day, the move appears material rather than random noise. Without access to company press releases, SEC filings, or trading-specific data, the most probable categories remain clinical or financial news, but this is inference rather than fact based solely on what a biotech stock's typical drivers are.

EZRA

Reliance Global Group, Inc.Financial Services

$2.21−$0.42

-16.2%

NASDAQ · Mkt cap $2.0 M

No news headlines were found in the last 48 hours for EZRA, so the 16.15% drop cannot be directly attributed to a specific announced catalyst. The decline may reflect technical selling, broader market weakness, or untracked developments.

The absence of any Yahoo Finance headlines in the last 48 hours means we cannot identify a specific corporate event or news driver for today's 16.15% decline. Reliance Global Group is a small-cap NASDAQ stock, and moves of this magnitude without concurrent headline coverage typically fall into a few categories: technical or algorithmic selling triggered by price action or volume thresholds, broad market selloff affecting micro-cap stocks disproportionately, delayed disclosure of negative information not yet picked up by major news feeds, insider activity or regulatory filing that precedes headline coverage, or sentiment shifts around the sector or company fundamentals that haven't been formally announced. Without access to real-time order flow data, SEC filings from the past 48 hours, or broker commentary, we cannot distinguish among these possibilities.

UAVS

AgEagle Aerial Systems IncTechnology

$0.91−$0.17

-16.1%

NYSE · Mkt cap $57 M

No news headlines were found in the last 48 hours to explain AgEagle's 16% drop, so the decline likely stems from technical selling, sector rotation, or undisclosed company developments.

AgEagle Aerial Systems experienced a significant single-day decline of 16.1% with no corresponding news headlines in the prior 48 hours according to the data provided. This disconnect between price action and public information suggests the move was either driven by technical factors such as stop-loss orders or margin calls, broader market sentiment affecting small-cap aerospace or drone companies, or material information that has not yet appeared in major news feeds. Micro-cap stocks like UAVS trading at $0.91 are frequently subject to high volatility and thin liquidity, which can amplify price moves on modest volume. Without specific catalysts identified in available headlines, the decline could also reflect delayed market reaction to prior news, insider activity, or internal company developments not yet publicly disclosed.

CANG

Cango Inc-KYFinancial Services

$1.74−$0.33

-15.9%

NYSE · Mkt cap $69 M

No news headlines were found in the last 48 hours, so the 15.94% drop on CANG cannot be directly attributed to a reported catalyst; the decline likely stems from technical selling, sector-wide weakness, or an unannounced event.

The absence of any news in the recent Yahoo Finance RSS feed makes it impossible to pinpoint a specific catalyst for CANG's sharp 15.94% decline on 2026-08-17. For a micro-cap or lower-liquidity stock like CANG trading at $1.74, price swings of this magnitude can occur from several sources. First, technical factors such as stop-loss cascades or option expiration mechanics can trigger sharp single-day moves even without news. Second, sector-specific headwinds affecting automotive or financial services stocks (CANG operates in vehicle transactions and financing) could suppress valuations broadly. Third, an unannounced insider transaction, regulatory filing, earnings leak, or social-media rumor might have circulated but not yet reached traditional financial news aggregators. Without headline confirmation or structural insight into CANG's capital stack or short-interest profile, the drop remains unexplained by the available evidence.

BIVI

BioVie Inc.Healthcare

$1.18−$0.22

-15.7%

NASDAQ · Mkt cap $10 M

No news headlines were available in the last 48 hours to explain BioVie's 15.71% drop, so the catalyst remains unclear and could stem from clinical trial setbacks, insider selling, broader biotech weakness, or other undisclosed developments.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to pinpoint a specific event driving the decline. BioVie is a small-cap biotech company, and stocks in this category are often volatile and sensitive to multiple potential triggers that may not be immediately or widely reported. Common causes for such sharp drops in early-stage biotech firms include negative clinical trial results, unfavorable regulatory feedback, management changes, funding concerns, dilutive capital raises, or shifts in investor sentiment toward the broader biotech sector. The stock's low price of $1.18 and its ranking as the 49th biggest loser suggests genuine selling pressure rather than normal intraday noise. Without access to company filings, regulatory announcements, or investor relations updates beyond what appears in major news feeds, determining the root cause is speculative.

MOBQ

Mobiquity Technologies, Inc.Communication Services

$0.70−$0.13

-15.7%

NASDAQ · Mkt cap $19 M

No news headlines were found in the last 48 hours, so the 15.66% drop cannot be directly attributed to a disclosed event. The decline may reflect broader micro-cap sell pressure, technical deterioration, or unreported developments in the market.

The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for MOBQ's sharp 15.66% decline. Mobiquity Technologies is a micro-cap stock trading at $0.70, a price point associated with higher volatility and lower institutional coverage. Stocks at this level are susceptible to multiple drivers: technical support breaks that trigger algorithmic selling, changes in short positions or market maker behavior, delayed announcements that circulate via social media before reaching major news feeds, sector-wide weakness in mobile or technology services, or deterioration in company fundamentals not yet publicly disclosed. Without either news or structural knowledge about MOBQ's current capital structure or trading dynamics, it is difficult to distinguish between operational setbacks and pure technical or sentiment-driven selling.